France comprises Metropolitan France and several Overseas Departments and Regions, with healthcare administration coordinated nationally but delivered regionally through Regional Health Agencies (Agences Régionales de Santé). Funded primarily through social health insurance contributions and general taxation, the health system has established processes for medical evaluation, health technology assessment based on therapeutic value and improvement over existing treatments, with pricing negotiations based on comparative clinical benefit, and arrangements to ensure early patient access to innovative therapies.
Each stage of the national access process is summarised via the dropdown menu visible to subscribers. Summaries contain links to more detailed briefings, which can also be found by selecting topics on the search page accessed by the button below: